“third-rock-ventures” Archives

in
Entry Author Date Location
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
Boston’s Life Science Disruptors 2015: The Photos 10/06/15 Boston
Five Takeaways From “Boston’s Life Science Disruptors” 10/02/15 Boston
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
Neon Therapeutics Obtains $55,000,000 Series A Funding Round 10/02/15 Boston
With $55M, Neon Wants To Make the Cancer Vaccine “Problem” Personal 10/01/15 Boston
Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO 09/28/15 San Francisco
Celgene Cozies up to Nurix With $150M Drug Development Deal 09/16/15 San Francisco
Hear the Synlogic Story at Boston’s Life Science Disruptors Sept. 30 09/14/15 Boston
East Coast Biotech Roundup: Biogen, Watson, Data Dumps & More 09/11/15 Boston
With $229M Deal, Amicus Gets a New Drug And Perhaps a Voucher 08/31/15 New York
Constellation Pharma Plots IPO Run As Genentech Passes on Buyout Deal 08/24/15 Boston
Global Blood Thera Nabs $120M IPO, Doubles Share Price On First Day 08/11/15 San Francisco
CRISPR Race Heats Up As Gates, Crossovers Put $120M Into Editas 08/10/15 Boston
“Boston’s Life Science Disruptors” to Share Their Stories on Sept. 30 07/23/15 Boston
FDA Grants Blueprint Go-Ahead for Kinase Inhibitor Trials 07/13/15 Boston
Tackling Sickle Cell, Global Blood Therapeutics Joins IPO Queue 07/08/15 San Francisco
Good Times Roll on for Biotech VCs As Clarus Bags New $500M Fund 06/09/15 Boston
Eleven Bio’s Shares Routed as Dry Eye Drug Flunks Phase 3 Test 05/18/15 Boston
Ex-AstraZeneca Exec to Lead Surface’s “Next-Gen” Immuno-Oncology Plan 05/07/15 Boston
With $46M Haul, MyoKardia Becomes Third Rock’s Latest IPO Prospect 04/30/15 San Francisco
Blueprint Medicines Bags $147M in Upsized IPO 04/29/15 Boston
Crossovers Arm Jounce With $56M For “Next Step” Immuno-Oncology 04/23/15 Boston
Dunsire, Forum Pharma Look Beyond Fidelity For Big Alzheimer’s Push 04/22/15 Boston
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups 04/17/15 Boston
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
Doudna’s Caribou Bio Raises $11M To Expand Uses For Gene Editing Tech 04/02/15 San Francisco
Flagship Ventures Raises Sails for $537M Fund, Its Largest to Date 03/26/15 Boston
Alexion Deal in Hand, Blueprint Readies IPO Pitch 03/23/15 Boston
Page 2 of 15 « previous page · next page »